Patent · US Active

HER2 binders

US11633507B2 · kind B2 · utility

0Cited by
16References
8Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 10, 2020
Grant dateApr 25, 2023
Priority date
Expiry dateDec 10, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/71
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.